Clinical News

While MTM is proving to be effective, a different version, collaborative drug therapy management could be the best model for diseases like diabetes.

Blood glucose meters have come a long way and the newest models can track patterns, in addition to the standard monitoring.

FDA approved a single shared Risk Evaluation and Mitigation Strategy (REMS) for all mycophenolate-containing prescription drugs at the end of September.

Cleansing laxatives approved for prescription use before colonscopy

Is your health system is having an epidemic of CLABSIs? CUSP can help save lives and money.

FDA and the CDC confirm that the fungus Exserohilium rostratum contaminated one of the three implicated lots of preservative-free methylprednisone acetate (80 mg/mL) from the New England Compounding Center which the company recalled September 26.

Anticoagulation therapies reviewed, including Merck moving forward with FDA approval of vorapaxar despite bleeding risks

There is considerable discrepancy among caregivers and pharmacists regarding the appropriate dosage of acetaminophen for overweight and obese children.

A fixed-dose combination of azilsartan medoxomil plus chlorthalidone was statistically superior to azilsartan medoxomil coadministered with hydrochlorothiazide at reducing and maintaining systolic blood pressure.

Men who developed sexual side effects from finasteride have been shown to suffer from depressive symptoms and suicidal thoughts, said a recent study.

A recent study indicates that patients taking statins are at a higher risk of developing cataracts at an earlier age than those not taking them.

FDA approves Prepopik and a new indication for Truvada.

Treatment with omega-3 polyunsaturated fatty acids to prevent cardiovascular disease has been controversial.

Patients taking long-term warfarin who had bleeding from their gastrointestinal tract should resume warfarin once the bleeding episode is under control, to reduce their risk of thrombosis.

Patients suffering stroke often do not seek immediate help. Just as disturbing, lack of stroke expertise in many hospitals and skepticism among ER physicians may prevent tPA from being administered to the patients who need it most.

FDA approves Lorcaserin and Mirabegron extended-release tablets.

Ticagrelor is shown to be better at platelet inhibition. Warfarin seen as beneficial to patients with PAH. Dabigatran's problems aren't over.

Findings at the International AIDS Conference support the need to start antiretroviral therapy as soon as possible after diagnosis.

FDA approved enzalutamide (Xtandi, Astellas Pharma U.S. Inc. and Medivation) to treat men with late-stage (metastatic) castration-resistant prostate cancer that has spread or recurred, even with medical or surgical therapy to minimize testosterone.

Higher starting doses of allopurinol to treat gout may increase the risk for allopurinol hypersensitivity syndrome, according to a study published in the August 2012 issue of Arthritis & Rheumatism.

Individuals taking statins are at higher risk of developing cataract at an earlier age than those not taking them, according to a study published in the August issue of Optometry and Vision Science.

Growth hormone-releasing hormone shows favorable effects on cognition in older adults and those with mild cognitive impairment, according to a study published in the Archives of Neurology.

Caffeine may offer promise to patients with Parkinson disease by easing movement symptoms, according to a small study published August 1 in Neurology.

Aminoglycoside-loaded bone cement implants, frequently used in orthopedic surgery, may result in systemic effects that raise aminoglycoside serum concentrations and lead to acute kidney injury, according to a study published July 3 in The Annals of Pharmacotherapy.

Vitamin D deficiency in critically ill children may make them more vulnerable to severe illnesses, according to two new studies published ahead of the print September issue of Pediatrics.

FDA approved Mylan Pharmaceutical's 15-mg, 30-mg, and 45-mg pioglitazone hydrochloride tablets, the first generic version of Actos (Takeda), along with diet and exercise to improve blood glucose control in adults with type 2 diabetes.

FDA’s latest “Drug Info Rounds†video for health professionals helps pharmacists understand the agency’s Accelerated Approval Program for drugs when there is an unmet medical need.

It’s important to put processes in place to be sure a patient’s medication list at discharge from the hospital is the same information that is provided to the primary care physician to avoid medication errors, according to a recent study published online July 24 in The Annals of Pharmacotherapy.

FDA has approved the influenza vaccine formulation for six manufacturers for the 2012-2013 influenza season.

FDA has approved vincristine sulfate liposome injection for the treatment of adult patients with Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL) who have had at least two relapses or whose disease has progressed following two or more anti-leukemia therapies.